Clinical Trial Update: Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

View source ↗

Summary

Clinical trial update for a lentiviral gene therapy (Zamtocabtagene Autoleucel) in non-Hodgkin lymphoma, noting ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zamtocabtagene Autoleucel

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: Non Hodgkin Lymphoma | Status: RECRUITING